ScoreComparison
Why is AbCellera Biologics, Inc. ?
1
With a growth in Net Sales of 96.34%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- NET PROFIT(HY) Higher at USD -52.91 MM
- NET SALES(Q) At USD 8.32 MM has Grown at 96.34%
- RAW MATERIAL COST(Y) Fallen by -91.06% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 202.45%, its profits have risen by 2.3%
3
High Institutional Holdings at 54.64%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.12% over the previous quarter.
4
Market Beating Performance
- The stock has generated a return of 202.45% in the last 1 year, much higher than market (S&P 500) returns of 28.21%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to AbCellera Biologics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is AbCellera Biologics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
AbCellera Biologics, Inc.
202.45%
0.95
79.82%
S&P 500
28.21%
2.23
12.67%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-33.11%
EBIT Growth (5y)
-196.53%
EBIT to Interest (avg)
-96.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.04
Tax Ratio
20.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
53.52%
ROCE (avg)
43.54%
ROE (avg)
8.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.12
EV to EBIT
-2.16
EV to EBITDA
-2.49
EV to Capital Employed
1.26
EV to Sales
15.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-58.25%
ROE (Latest)
-17.81%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
NET PROFIT(HY)
Higher at USD -52.91 MM
NET SALES(Q)
At USD 8.32 MM has Grown at 96.34%
RAW MATERIAL COST(Y)
Fallen by -91.06% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 0.65 times
-4What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -153.54 MM
CASH AND EQV(HY)
Lowest at USD 1,090.06 MM
Here's what is working for AbCellera Biologics, Inc.
Net Sales
At USD 8.32 MM has Grown at 96.34%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -52.91 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debtors Turnover Ratio
Highest at 0.65 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -91.06% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 8.66 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for AbCellera Biologics, Inc.
Operating Cash Flow
Lowest at USD -153.54 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Cash and Eqv
Lowest at USD 1,090.06 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
